Drug profile

The FDA adverse-event record for Unknown Gabapentin

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unknown Gabapentin. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
26.7%
death-coded share
Dog
most-reported species
4
Seizure NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
4
Deaths Reported
26.7%
Death Rate

Active Ingredients

Unknown Gabapentin

Administration Routes

UnknownOral

Species Affected

Dog 15

Most Affected Breeds

Retriever - Labrador 5
Collie - Border 2
Spaniel - King Charles Cavalier 2
Terrier - Jack Russell 1
Retriever - Golden 1
Terrier - Bull - American Pit 1
Rottweiler 1
Shepherd Dog - Australian 1
Boxer (German Boxer) 1

Most Reported Reactions

Seizure NOS 4
Musculoskeletal disorder NOS 3
Intentional misuse 3
Diarrhoea 2
Vomiting 2
Neurological signs NOS 2
Disorientation 2
Death 2
Ataxia 2
Death by euthanasia 2
Partial lack of efficacy 2
Stumbling gait 2

Outcome Breakdown

Ongoing
6 (40.0%)
Outcome Unknown
3 (20.0%)
Recovered/Normal
2 (13.3%)
Died
2 (13.3%)
Euthanized
2 (13.3%)

Unknown Gabapentin Adverse Event Insights

15 reports name Unknown Gabapentin; 4 recorded a death outcome (26.7% of reported events, not a population-level mortality rate). Active ingredient: Unknown Gabapentin. Administration routes: Unknown, Oral.

By species: Dog (15 reports). By breed: Retriever - Labrador (5), Collie - Border (2), Spaniel - King Charles Cavalier (2).

Leading clinical signs: Seizure NOS (4), Musculoskeletal disorder NOS (3), Intentional misuse (3), Diarrhoea (2). Outcome, 15 coded reports: Ongoing leads at 40.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.